Activation of nuclear factor κB by polyamines in breast cancer cells

被引：0
|
作者：
Department of Medicine, Univ. of Med. and Dent. of NJ, Robert Wood Johnson Medical School, New Brunswick, NJ 08903, United States [1 ]
不详 [2 ]
不详 [3 ]
不详 [4 ]
不详 [5 ]
不详 [6 ]
不详 [7 ]
机构：
来源：
Biochem | / 45卷 / 14763-14774期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Activation of nuclear factor κB by polyamines in breast cancer cells
    Shah, N
    Thomas, T
    Shirahata, A
    Sigal, LH
    Thomas, TJ
    BIOCHEMISTRY, 1999, 38 (45) : 14763 - 14774
  • [2] Role of polyamines in the function of nuclear transcription factor NF-κB in breast cancer cells
    Zaletok, S
    Alexandrova, N
    Berdynskykh, N
    Ignatenko, N
    Gogol, S
    Orlovsky, E
    Tregubova, N
    Gerner, E
    Chekhun, V
    EXPERIMENTAL ONCOLOGY, 2004, 26 (03) : 221 - 225
  • [3] Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells
    Neha Shah
    T J Thomas
    Joan S Lewis
    Carolyn M Klinge
    Akira Shirahata
    Celine Gelinas
    Thresia Thomas
    Oncogene, 2001, 20 : 1715 - 1729
  • [4] Regulation of estrogenic and nuclear factor κB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells
    Shah, N
    Thomas, TJ
    Lewis, JS
    Klinge, CM
    Shirahata, A
    Gelinas, C
    Thomas, T
    ONCOGENE, 2001, 20 (14) : 1715 - 1729
  • [5] Activation of a nuclear factor κB/interieukin-1 positive feedback loop by amphiregulin in human breast cancer cells
    Streicher, Katie L.
    Willmarth, Nicole E.
    Garcia, Jose
    Boerner, Julie L.
    Dewey, T. Gregory
    Ethier, Stephen P.
    MOLECULAR CANCER RESEARCH, 2007, 5 (08) : 847 - 861
  • [6] Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-κB Activation
    Wang, Wei
    Zhang, Bo
    Mani, Arul M.
    Wu, Zhongzhi
    Fan, Yu
    Li, Wei
    Wu, Zhao-Hui
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 366 (01): : 184 - 193
  • [7] Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patients
    Montagut, C.
    Tusquets, I.
    Ferrer, B.
    Corominas, J. M.
    Bellosillo, B.
    Campas, C.
    Suarez, M.
    Fabregat, X.
    Campo, E.
    Gascon, P.
    Serrano, S.
    Fernandez, P. L.
    Rovira, A.
    Albanell, J.
    ENDOCRINE-RELATED CANCER, 2006, 13 (02) : 607 - 616
  • [8] Activation of NFκB in breast cancer cells
    Nehra, Ruchi
    Riggins, Rebecca B.
    Zwart, Alan L.
    Clarke, Robert
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Triptolide sensitizes human breast cancer cells to tumor necrosis factor-κ-induced apoptosis by inhibiting activation of the nuclear factor-κB pathway
    Cheng, Xiaoli
    Shi, Wenli
    Zhao, Canguo
    Zhang, Dan
    Liang, Piao
    Wang, Guohui
    Lu, Li
    MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3257 - 3264
  • [10] Mutant p53 enhances nuclear factor κB activation by tumor necrosis factor α in cancer cells
    Weisz, Lilach
    Damalas, Alexander
    Liontos, Michalis
    Karakaidos, Panagiotis
    Fontemaggi, Giulia
    Maor-Aloni, Revital
    Kalis, Marina
    Levrero, Massimo
    Strano, Sabrina
    Gorgoulis, Vassilis G.
    Rotter, Varda
    Blandino, Giovanni
    Oren, Moshe
    CANCER RESEARCH, 2007, 67 (06) : 2396 - 2401
12345